Staging Alzheimer's Disease Using Blood Samples

Project Summary

Researchers will develop a staging model for Alzheimer’s disease based on plasma biomarkers, which will help characterize people across the different phases of the disease. The study will also investigate how multiple protein levels change across these stages to better understand the complex biological processes that occur during the disease. Researchers envision that the staging model may help decide, in an easy and cost-effective way, who would benefit from a treatment against Alzheimer's disease and perform a more personalized management of the individual. Studying protein changes may also unveil new drug targets for Alzheimer’s.